A diffusing applicator is provided and generally includes a head unit, and extension shaft, and a dispensing device. The head unit includes a fluid receiving space and a plurality of dispensing passageways in communication the fluid receiving space. The extension shaft is securely connected to the head unit. The dispensing device is for holding a fluid and is connected to the extension shaft. The dispensing device is in communication with the plurality of dispensing passageways and urges fluid through extension shaft and through the dispensing passageways.

The present disclosure relates generally to systems and methods for performing endoscopic procedures, and, more particularly, to location and access devices, systems, and methods for gastrojejunostomy procedures. In an aspect a medical device locator may include an elongate member having a proximal end, a distal end, a longitudinal axis, and a length extending along the longitudinal axis. An inflatable member may be disposed about the distal end of the elongate member. The inflatable member may have a first inflated volume and a second inflated volume larger than the first inflated volume. The elongate member may include a fluid lumen extending therealong. The fluid lumen may be in fluid communication with the inflatable member and may be configured to pulsate the inflatable member between the first inflated volume and the second inflated volume.

A method is used for closing, and confirming closure of, the left atrial appendage of the heart of a patient. The method includes using an assembly for closing the left atrial appendage. The method also includes using a system for confirming closure of the left atrial appendage after the left atrial appendage has been closed by the assembly.

The present invention is directed to dry lyophilized foam plugs that are a polymeric reaction product of at least a pair of co-reactive polyethylene glycol having reactive moieties in which substantially all of reactive moieties have reacted prior to lyophilization or blend of biomaterial and a reactive polyethylene glycol or plasma derived biomaterial reaction product and wherein the plug has an overall pore void content of about 30-45%, and a microporous structure with an average pore generally between 20 and 95 μm.

Systems and methods of reconstructing photoacoustic imaging data corresponding to a brain of a subject through a skull of a subject utilizing a reconstruction method that incorporates a spatial model of one or more acoustic properties of the brain and skull of the subject derived from an adjunct imaging dataset.

A method of making a high flexibility distal zone on a neurovascular catheter is provided. The method includes the steps of dip coating a removable mandrel to form a tubular inner layer on the mandrel, coating the tubular inner layer with a tie layer, applying a helical coil to the outside of the tie layer, positioning a plurality of tubular segments, heating the tubular segments to form the high flexibility distal zone on the neurovascular catheter; and removing the mandrel.

A device and method are provided for storing a prefilled liquid beverage, receiving an oral contrast imaging agent that is mixed with the prefilled liquid beverage, and dispensing a resulting beverage/oral contrast imaging agent mixture. The device has a body defining a chamber for storing the prefilled liquid beverage. A closure is movable between a closed position for sealing the prefilled liquid in the chamber, and an open position for (i) introducing the oral contrast imaging agent into the chamber for mixture with the prefilled liquid beverage, and (ii) dispensing the beverage/oral contrast imaging agent mixture. The device may include first graduations, a time scale and second graduations. The body defines a substantially smooth, axially extending patient information surface including thereon a plurality of marking spaces and respective patient information indicia associated with each marking space for marking thereon information relating to a respective patient.

A rapid exchange type medical elongated body is disclosed in which an outer diameter of a distal portion of a tubular member is set smaller than an outer diameter of a proximal portion of the tubular member, which prevents an occurrence of a kink in a physical property change region of the medical elongated body which has a relatively large change in physical property. A tubular member forming a second region of a distal member of a medical elongated body is integrally formed with a shaft portion. The distal member has a reinforcement layer containing a metallic material and formed between an inner layer and an outer layer from a first region to the second region. The reinforcement layer is disposed inside the tubular member in the second region. An outer diameter of the first region is set smaller than an outer diameter of the second region.

A rapid exchange type medical elongated body is disclosed in which an outer diameter of a distal portion of a tubular member is set smaller than an outer diameter of a proximal portion of the tubular member, which prevents an occurrence of a kink in a physical property change region of the medical elongated body which has a relatively large change in physical property. A tubular member forming a second region of a distal member of a medical elongated body is integrally formed with a shaft portion. The distal member has a reinforcement layer containing a metallic material and formed between an inner layer and an outer layer from a first region to the second region. The reinforcement layer is disposed inside the tubular member in the second region. An outer diameter of the first region is set smaller than an outer diameter of the second region.

The invention locally delivers a chemotherapeutic or a radiographic contrast agent to an upper tract urothelial carcinoma (UTUC). The invention includes a balloon catheter with a working channel and a balloon placed into the ureter/renal pelvis via retrograde or antegrade ureteral access. The balloon is inflated to temporarily obstruct the ureter, and a formulation with a chemotherapeutic agent is infused into the working channel of the catheter and allowed to dwell in the ureter/renal pelvis for a time sufficient to allow the formulation to adhere to and penetrate the urothelial wall. The formulations can be liposomal or non-liposomal formulations. At least portion of the infused chemotherapeutic-agent formulation adheres to the urothelial wall while it is instilled and dwells in the ureter/renal pelvis. The methods of the invention can be performed as an adjuvant therapy to other methods of treating UTUC, including ureteroscopic ablation or resection of the tumor.